InMode Ltd INMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INMD is a good fit for your portfolio.
News
-
INMD DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMD
-
DEADLINE ALERT for INMD, AMPL, and NOVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
-
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
-
Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD
-
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm
-
INMD 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages InMode Ltd. (INMD) Investors with $100K+ Losses to Contact Firm’s Attorneys Before Apr. 15th Deadline in Securities Class Action
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode
-
INMD Investors Have Opportunity to Lead InMode Ltd. Securities Fraud Lawsuit
Trading Information
- Previous Close Price
- $17.41
- Day Range
- $16.98–17.55
- 52-Week Range
- $16.96–48.25
- Bid/Ask
- $17.01 / $17.24
- Market Cap
- $1.45 Bil
- Volume/Avg
- 1.2 Mil / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 6.83
- Price/Sales
- 3.00
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 581
- Website
- https://www.inmodemd.com
Comparables
Valuation
|
Metric
|
INMD
|
MMSI
|
SMTI
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.83 | 24.34 | — |
Price/Book Value | 1.83 | 3.53 | 6.26 |
Price/Sales | 3.00 | 3.40 | 4.19 |
Price/Cash Flow | 6.75 | 19.87 | 8,081.55 |
Price/Earnings
INMD
MMSI
SMTI
Financial Strength
|
Metric
|
INMD
|
MMSI
|
SMTI
|
|---|---|---|---|
Quick Ratio | 12.24 | 3.81 | 0.99 |
Current Ratio | 13.18 | 5.45 | 1.38 |
Interest Coverage | — | 8.07 | −8.33 |
Quick Ratio
INMD
MMSI
SMTI
Profitability
|
Metric
|
INMD
|
MMSI
|
SMTI
|
|---|---|---|---|
Return on Assets (Normalized) | 29.90% | 9.43% | −6.84% |
Return on Equity (Normalized) | 33.22% | 14.77% | −10.51% |
Return on Invested Capital (Normalized) | 30.04% | 11.47% | −8.32% |
Return on Assets
INMD
MMSI
SMTI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tsmmxqhx | Sbjzkvd | $185.8 Bil | |
SYK
| Stryker Corp | Xjlvshwr | Nbkf | $124.7 Bil | |
MDT
| Medtronic PLC | Vdngcspf | Ryyplqk | $105.2 Bil | |
BSX
| Boston Scientific Corp | Kdwpqqf | Zwrtnf | $99.0 Bil | |
EW
| Edwards Lifesciences Corp | Wclvrqbvwz | Kblvbbx | $52.3 Bil | |
DXCM
| DexCom Inc | Hbqhvyyxrt | Jbcld | $52.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qvhxysmsj | Qdqg | $24.8 Bil | |
ALGN
| Align Technology Inc | Qxtckrp | Dmfdsb | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Mvhcgyh | Wgfvzx | $18.5 Bil | |
PODD
| Insulet Corp | Sfzpmnnlc | Yssgcn | $11.5 Bil |